BKMIX
Price
$10.62
Change
-$0.03 (-0.28%)
Updated
Jun 23 closing price
Net Assets
10.48B
FMUCX
Price
$16.61
Change
-$0.10 (-0.60%)
Updated
Jun 23 closing price
Net Assets
1.46B
Interact to see
Advertisement

BKMIX vs FMUCX

BKMIX vs FMUCX Comparison Chart in %
View a ticker or compare two or three
VS
BKMIX vs. FMUCX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BKMIX is a Hold and FMUCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BKMIX has more cash in the bank: 10.5B vs. FMUCX (1.46B). BKMIX pays higher dividends than FMUCX: BKMIX (5.96) vs FMUCX (1.01). BKMIX was incepted earlier than FMUCX: BKMIX (9 years) vs FMUCX (23 years). FMUCX (1.84) is less costly to investors than BKMIX (0.62). BKMIX is a more actively managed with annual turnover of: 99.00 vs. FMUCX (31.00). FMUCX has a lower initial minimum investment than BKMIX: FMUCX (1500) vs BKMIX (5000000). FMUCX annual gain was more profitable for investors over the last year : 15.55 vs. BKMIX (9.37). BKMIX return over 5 years is better than : 21.86 vs. FMUCX (19.94).
BKMIXFMUCXBKMIX / FMUCX
Total Expense Ratio0.521.7430%
Annual Report Gross Expense Ratio0.621.8434%
Fund Existence9 years23 years-
Gain YTD3.1926.02953%
Front LoadN/AN/A-
Min. Initial Investment50000001500333,333%
Min. Initial Investment IRAN/A250-
Net Assets10.5B1.46B722%
Annual Yield % from dividends5.961.01589%
Returns for 1 year9.3715.5560%
Returns for 3 years32.1030.92104%
Returns for 5 years21.8619.94110%
Returns for 10 yearsN/A50.98-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVRMX26.49N/A
N/A
Franklin Mutual Small-Mid Cap Val Adv
MIDHX34.15N/A
N/A
MFS International New Discovery R3
LMARX69.76N/A
N/A
ClearBridge Small Cap R
CCALX69.72N/A
N/A
Conestoga Small Cap Institutional
AIHHX6.55N/A
N/A
Aristotle Small/Mid Cap Equity I-2